Gain detailed insights into the trading activity of Congress members for Deutsche Bank on our government trades page. Stay updated on how elected officials are investing in DB.

Deutsche Bank - Government Trades

Deutsche Bank

Deutsche Bank is a universal bank operating on a global scale. The bank offers corporate, retail, investment banking, private banking, and asset management to its clients.

6 Reasons Why Deutsche Bank Believes Stocks Are Likely In For Another Sharp Sell-Off

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$ETH

Sony Group Corporation American Depositary Shares

SONY

German lending behemoth, Deutsche Bank AG Inc. (NYSE:DB), was developing an Ethereum (CRYPTO: ETH) Layer-2 blockchain, according to a Wednesday report, the latest in a wave of growing interest in Web3 by tradit

Germany&#39;s Largest Bank Is Reportedly Leveraging Ethereum-Based Blockchain Solution To Overcome Regulatory Hurdles: Here&#39;s How

Cannabis,Leaf,On,Grunge,Background,,Shallow,Dof.

Cannabis

DBCCF

TSXV:DB

Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion

ibrahim-rifath-OApHds2yEGQ-unsplash(8)

Financing

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) has completed the second and final closing of its previously announced non-brokered private placement of its common shares at $0.06 per common share. The company said on Monday that, at the second closing of the offering, it issued 19,647,776 common shares for gross proceeds of roughly $1,178,867. The second closing was in addition to the previously announced first closing in November when Decibel issued 33,503,864 common shares for gross proceeds of approximately $2,010,232.

Decibel Cannabis Raises $1.18M, Secures Capital For AgMedica BioScience Integration

pexels-kindelmedia-7668049(1)

Earnings

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. &#34;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,&#34; CEO Benjamin Sze said. &#34;Maintaining discipline over time will result in a stronger balance sheet.  This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.&#34;

Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%

banks-ai3

Movers

Trading Ideas

Deutsche Bank shares are trading lower on Monday. A new Bloomberg report suggests a shareholder is preparing to sell 16 million shares of the German lender.

What&#39;s Going On With Deutsche Bank Stock Monday?

General

HSBC

Banks across the globe have been continuously undertaking restructuring efforts to focus more on core operations. While these efforts are expected to result in elevated expenses, they will aid growth in the long run.

3 Stocks To Consider From The Prospering Foreign Banks Industry

Stock_Whisper_Index_Logo_6-copy

Exclusives

GLMD

GOLD

The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.

Benzinga&#39;s &#39;Stock Whisper&#39; Index: 5 Stocks Investors Secretly Monitor But Don&#39;t Talk About Yet

AI-Generated Image

Analyst Color

Market Summary

Retail Sales

Analyst Ratings

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CRON

TLRY

The Canadian cannabis market is shifting towards newer product formats, with some segments outperforming cannabis flowers in sales.

Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls &amp; Vapes As Market Eyes C$5.47B

Business,Man,Sign,A,Contract,Investment,Professional,Document,Agreement.,Meeting

Equities

Legal

Media

Deutsche Bank reaches settlements with majority of plaintiffs regarding the litigation over the Postbank takeover and the offer price paid to former Postbank shareholders.

What&#39;s Going On With Deutsche Bank Stock Friday?

Large Cap

Mid Cap

PIPR

Deutsche Bank (NYSE: DB) has achieved notable progress in talks with claimants involved in the legal dispute regarding its takeover of Postbank and the compensation paid to former Postbank shareholders. 

Deutsche Bank Settles 60% of Claims Related to Postbank Takeover

Deutsche Bank AG

Invesco DB Agriculture Fund

Xtrackers MSCI All World ex US Hedged Equity ETF

Invesco DB Base Metals Fund

Invesco DB Commodity Index Tracking Fund

DeepBrain Chain

DECIBEL CANNABIS CO INC by Decibel Cannabis Co Inc.

Decibel Cannabis Co Inc

Diebold Nixdorf Incorporated Common stock

Diebold Nixdorf Inc

DOUBLEDRAGON CORP by DOUBLEDRAGON CORP.

Invesco DB Energy Fund

Xtrackers MSCI EAFE Hedged Equity ETF

Litman Gregory Funds Trust iMGP DBi Hedge Strategy ETF

Xtrackers MSCI Emerging Markets Hedged Equity ETF

Xtrackers MSCI Europe Hedged Equity ETF

Xtrackers MSCI Eurozone Hedged Equity ETF

DUXTON BROADACRE FRMS LTD by DUXTON BROADACRE FARMS LTD.

Duxton Farms Ltd

PANEX RESOURCES INC by Panex Resources Inc.

Panex Resources Inc

DIGITAL BRANDS GROUP INC by Digital Brands Group, Inc.

Digital Brands Group Inc

Digital Brands Group Inc Warrants (01/05/2026)

DBX ETF Trust Xtrackers MSCI Germany Hedged Equity ETF

Designer Brands Inc. Class A Common Stock

Designer Brands Inc

Dacotah Banks Inc

Innovator ETFs Trust DOUBLE STACKER 9 BUFFER ETF JANUARY

Xtrackers MSCI Japan Hedged Equity ETF

Spetz Inc Ordinary Shares

Spetz Inc

DoubleLine Opportunistic Credit Fund Common Shares of Beneficial Interest

Doubleline Opportunistic Credit Fund

DOUBLEVIEW GOLD CORP by Doubleview Gold Corp.

Doubleview Gold Corp

FIBRA Macquarie Certificados Bursatiles Fiduciarios Inmobiliario Series -12-

FIBRA Macquarie

iMGP DBi Managed Futures Strategy ETF

DBM Global Inc

DIGITAL BRAND M & M GRP by Digital Brand Media & Marketing Group, Inc.

Digital Brand Media & Marketing Group Inc

Cibanco S A Institucion De Banca Multiple ertificados Bursatiles Fiduciarios Inmobiliaro Series -12-

Cibanco S A Institucion De Banca Multiple

DoubleLine ETF Trust DoubleLine Opportunistic Bond ETF

Invesco DB Oil Fund

DEUTSCHE BOERSE AG NAMEN by Deutsche Boerse AG

Deutsche Boerse AG

DEUTSCHE BOERSE UNSP/ADR by Deutsche Boerse AG

Diablo Resources Ltd

D BOX TECHS INC ORD A by D-Box Technologies, Inc.

D-Box Technologies Inc

Invesco DB Precious Metals Fund

DigitalBridge Group Inc

DigitalBridge Group, Inc. 7.125% Series H

DigitalBridge Group, Inc. 7.125% Series J

DAYBREAK OIL & GAS INC by Daybreak Oil & Gas, Inc.

Daybreak Oil & Gas Inc

Fibra Inn Certificados Bursatiles Fiduciarios Inmobiliario Series -13-

Fibra Inn

DBS GROUP HLDGS LTD ORD by DBS Group Holdings Ltd.

DBS Group Holdings Ltd

DBS GROUP HLDGS LTD S/ADR by DBS Group Holdings Ltd.

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA

DBV TECHNOLOGIES SA by DBV Technologies SA

Dropbox Inc

XTRACKERS STX GLBL ETF 1D by Xtrackers

German lending behemoth, Deutsche Bank AG Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>), was developing an Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) Layer-2 blockchain, according to a Wednesday report, the latest in a wave of growing interest in Web3 by traditional financial giants.
What Happened: The solution was developed using ZKsync technology and was part of the Project Dama 2 experiment, which was unveiled in November, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-18/deutsche-bank-tries-to-tackle-compliance-hurdles-for-public-blockchains?utm_source=telegram&amp;utm_content=crypto&amp;utm_medium=social">reported</a>. 
The Layer-2 concept was an attempt to avoid the issues that regulated banks may have when working with public blockchains, such as transacting with criminals and sanctioned entities, according to bank executives quoted by Bloomberg.
A rollup, or a <a href="https://www.benzinga.com/money/what-are-layer-2-solutions-in-crypto">Layer-2 scaling solution</a>, offers the security of the Layer-1 chain and infrastructure while catering to enterprise needs for security and compliance. They allow for full customization, with only permissioned entities allowed to be as validators—participants that verify transactions.
Deutsche Bank didn&#8217;t immediately respond to Benzinga&#8217;s request to confirm this development. 
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42560698/microstrategys-aggressive-bitcoin-strategy-raises-eyebrows-in-crypto-community">MicroStrategy&#8217;s Aggressive Bitcoin Strategy Raises Eyebrows In Crypto Community</a>
Why It Matters: Project Dama 2 was part of the broader <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35499095/singapores-project-guardian-teams-up-with-top-financial-titans-for-asset-tokenization-pilo">&#8220;Project Guardian&#8221; initiative</a>, launched by Singapore&#8217;s central bank, the Monetary Authority of Singapore, to test the application of asset tokenization and decentralized finance across a broader range of use cases in the financial sector.
Participating financial institutions include names like JPMorgan, which <a href="https://www.benzinga.com/markets/asia/22/11/29552324/jpmorgan-executes-first-defi-transaction-for-singapores-project-guardian">previously conducted a cross-border transaction</a> on a public chain.
The move comes in the wake of similar initiatives by other major corporations. Earlier in August, multinational conglomerate&nbsp;Sony Group <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40521900/sony-group-set-to-launch-ethereum-layer-2-blockchain-soneium-heres-what-you-should-know">unveiled</a> its Ethereum Layer-2 blockchain, Soneium. The public blockchain, developed in collaboration with Web3 infrastructure, Startale Labs, hosts a range of Web3 games, NFT marketplaces, and entertainment-related services.
Deutsche Bank is the largest lender in Germany, with assets worth €1.31 trillion ($1.36 billion) as of Mar. 31, <a href="https://www.spglobal.com/market-intelligence/en/news-insights/research/europes-50-largest-banks-by-assets-2024">according </a>to S&amp;P Global.
Price Action:  Shares of Deutsche Bank closed 2.44% lower at $17.18 during Wednesday&#8217;s regular session and were down 1.05% in after-market trading, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. 
Image via Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42568122/trump-backed-world-liberty-financial-forges-partnership-with-ethena-labs-ena-token-gains-amid-broader-slump">Trump-Backed World Liberty Financial Forges Partnership With Ethena Labs — ENA Token Gains Amid Broader Slump</a></li>
</ul>

Germany's Largest Bank Is Reportedly Leveraging Ethereum-Based Blockchain Solution To Overcome Regulatory Hurdles: Here's How

Decibel Cannabis Company Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DB#TSXV">DB</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/DBCCF#OTCQB">DBCCF</a>) announced Tuesday that it has received final acceptance from the TSX Venture Exchange for its previously announced acquisition of a Canadian licensed producer of cannabis, AgMedica Bioscience Inc.
The acquisition, arranged through an agreement with Callisto Capital Corp. on October 28, 2024, was made in exchange for a <a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance">$6.3 million unsecured convertible debenture</a>. As a result of receiving the acceptance, Decibel has completed the conversion of the convertible debenture, pursuant to which it has issued 114.55 million common shares to Callisto.
The conversion of the convertible debenture was conditional upon receipt of final TSXV acceptance for the acquisition of AgMedica pursuant to Exchange Policy 5.3. This policy would have required approval from disinterested shareholders if Callisto became a major controller of the company. However, because the company has finished its recent private funding, Callisto will not control the company after the bond is converted. Therefore, approval from disinterested shareholders is not needed for the conversion.
Read Also: <a href="https://www.benzinga.com/24/12/42272602/cannabis-retail-giant-high-tide-launches-cabana-club-membership-program-in-us-eu-and-uk-with-new-product-categories">Cannabis Giant High Tide Taps Into $113 Billion Global E-Commerce Market With New Product Categories</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
On Nov. 25, the Calgary, Alberta-based cannabis company confirmed completion of the second and final closing of non-brokered private placement of its common shares at $0.06 per share. At the second closing of the offering, it issued 19.65 million shares for gross proceeds of <a href="https://www.benzinga.com/news/financing/24/11/42164794/decibel-cannabis-raises-1-18m-secures-capital-for-agmedica-bioscience-integration">roughly $1.18 million.</a>
Previously, Decibel projected that AgMedica could <a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance">contribute $30 million of net revenue</a> and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro-forma basis.
The transaction is expected to materially expand Decibel&#8217;s international footprint with EU GMP certification that enables export of flower and a variety of extract products, with proven sales to seven different countries including Australia, Denmark, Germany, Israel, Norway, Spain and the United Kingdom.
Price Action
Decibel shares closed Monday's market session 6.62% higher at $0.0499 per share.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53">Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%</a></li>
<li><a href="https://www.benzinga.com/markets/cannabis/24/12/42280135/health-canada-cuts-14-6m-from-cannabis-program-amid-federal-austerity">Health Canada Cuts $14.6M From Cannabis Program Amid Federal Austerity</a></li>
</ul>
Photo: Courtesy of pashabo&nbsp;via Shutterstock

Decibel Cannabis Company Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/DBCCF#OTCQB">DBCCF</a>) has completed the second and final closing of its previously announced non-brokered private placement of its common shares at $0.06 per common share.
<h3 class="wp-block-heading">What Happened</h3>
The company said on Monday that, at the second closing of the offering, it issued 19,647,776 common shares for gross proceeds of roughly $1,178,867.
The second closing was in addition to the previously announced first closing in November when Decibel issued 33,503,864 common shares for gross proceeds of approximately $2,010,232.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40577591/decibels-10m-strategy-how-it-could-enhance-your-canadian-cannabis-portfolio">Decibel's $10M Strategy: How It Could Enhance Your Canadian Cannabis Portfolio</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Why It Matters</h3>
Decibel said the proceeds of the offering will be used to work on and help integrate the integration of AgMedica BioScience Inc. which he company previously<a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance"> acquired</a>. The acquisition was arranged through an agreement with Callisto Capital on Oct. 28 and was made in exchange for a $6.3 million unsecured convertible debenture.
Decibel projects that AgMedica could contribute $30 million of net revenue and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro forma basis.
The company recently <a href="https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53">announced</a> its unaudited interim financial results on Thursday for the third quarter revealing CA$24.1 million ($17.2 million) in net revenue representing a 9% increase sequentially, but a 12% decrease year-over-year. However, gross margin before fair value adjustments reached 53% for the period, up from 44% in the prior year&#8217;s period, reflecting improved operational efficiency.
<h3 class="wp-block-heading">What's Next</h3>
The offering is subject to the receipt of all regulatory approvals including the final approval of the TSX Venture Exchange (TSXV).
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40369534/decibel-cannabis-reports-22-yoy-decrease-in-q2-net-revenue-plans-to-benefit-with-new-product-lau">Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches</a></li>
</ul>
<h3 class="wp-block-heading">DBCCF Price Action</h3>
Decibel's shares traded 1.45% higher at $0.0476 per share after the market close on Friday afternoon.

Decibel Cannabis Company Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DB#TSXV">DB</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/DBCCF#OTCQB">DBCCF</a>) announced its unaudited interim financial results on Thursday for the third quarter ending Sept. 30, 2024.
&#8220;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter," CEO Benjamin Sze said.&nbsp;"Maintaining discipline over time will result in a stronger balance sheet.&nbsp; This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40369534/decibel-cannabis-reports-22-yoy-decrease-in-q2-net-revenue-plans-to-benefit-with-new-product-lau">Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Q3 Financial Highlights</h3>
<ul>
<li>Net revenue totaled CA$24.1 million ($17.2 million), representing a 9% increase sequentially, but a 12% decrease year-over-year.</li>
<li>Gross profit before fair value adjustments was CA$12.7 million, compared to roughly CA$12 million in the prior year's period.</li>
<li>Gross margin before fair value adjustments reached 53% in the third quarter, up from 44% in the prior year's period, reflecting improved operational efficiency.</li>
<li>Adjusted EBITDA was positive at CA$5.1 million, representing a 31% increase from the previous quarter but a 21% decrease year over year.</li>
<li>Net loss and comprehensive loss amounted to CA$585 000, compared to a net income and comprehensive income of CA$413 000.</li>
<li>Generated positive free cash flow of $1.8 million, up 75% year-over-year.</li>
</ul>
The company said that it's seeing significant demand for its flower internationally as it continues to integrate AgMedica.
Decibel <a href="https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance">closed the acquisition</a> of AgMedica Bioscience Ltd. in October. The transaction was arranged through an agreement with Callisto Capital Corp. and was made in exchange for a $6.3 million unsecured convertible debenture.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40577591/decibels-10m-strategy-how-it-could-enhance-your-canadian-cannabis-portfolio">Decibel&#8217;s $10M Strategy: How It Could Enhance Your Canadian Cannabis Portfolio</a></li>
</ul>
<h3 class="wp-block-heading">DBCCF Price Action</h3>
Decibel's shares traded 5.54% higher at $0.0495 per share after the market close on Thursday afternoon.

PSFE

Paysafe Partners With Deutsche Bank To Offer Seamless Cash Deposit And Withdrawal Services For Postbank Customers In Germany, Launching November 2024 With Expansion To Deutsche Bank Planned For 2025

&ldquo;Our nine-month 2024 results underline Deutsche Bank&rsquo;s operating strength,&rdquo; added James von Moltke, Chief Financial Officer. &rdquo;We have consistently delivered on our guidance for both revenue growth and cost discipline; our capital and balance sheet are strong, and overall loan book quality remains solid. Looking ahead, this gives us confidence that we will meet our &euro; 30 billion revenue guidance for the year 2024 and that our continued revenue momentum, cost efficiencies, capital strength and moderating credit provisions all put us on track to deliver on our 2025 goals.&rdquo;

Guidance

Deutsche Bank 2024 Outlook: Revenue On Track For €30B (Vs. €29.44B Est.) Target, Cost Control Measures Ongoing; €1.8B Credit Loss Provision

Earnings Beats

Deutsche Bank Reports Q3 Common Equity Tier 1 Capital Ratio13.8%, Leverage Ratio 4.6%, Liquidity Coverage Ratio Was 135% And Provision For Credit Losses €494M

Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) reported quarterly earnings of €0.81 per share which beat the analyst consensus estimate of €0.40 by 102.5 percent. This is a 44.64 percent increase over earnings of €0.56 per share from the same period last year. The company reported quarterly sales of €7.501 billion which beat the analyst consensus estimate of €7.049 billion by 6.41 percent. This is a 5.53 percent decrease over sales of €7.940 billion the same period last year.

Deutsche Bank Q3 2024 GAAP EPS €0.81 Beats €0.40 Estimate, Sales €7.501B Beat €7.049B Estimate

Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) will release its quarterly earnings report on Wednesday, 2024-10-23. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Deutsche Bank to report an earnings per share (EPS) of $0.58.
Investors in Deutsche Bank are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
The company's EPS missed by $0.21 in the last quarter, leading to a 1.23% increase in the share price on the following day.
Here's a look at Deutsche Bank's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.58</td>
<td>0.70</td>
<td>0.34</td>
<td>0.52</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.75</td>
<td>0.72</td>
<td>0.61</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729605659_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Deutsche Bank were trading at $17.47 as of October 21. Over the last 52-week period, shares are up 61.53%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/DB/earnings">To track all earnings releases for Deutsche Bank visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of Deutsche Bank's Earnings Potential

Deutsche Bank AG Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) shares are trading lower on Monday. A new Bloomberg report suggests a shareholder is preparing to sell 16 million shares, valued at approximately $279 million, of the German lender. Here&#8217;s<a href="https://www.benzinga.com/trading-ideas/24/09/41095830/3-stocks-to-consider-from-the-prospering-foreign-banks-industry"> what you need to know.</a>
What To Know: <a href="https://www.bloomberg.com/news/articles/2024-10-14/deutsche-bank-shareholder-is-looking-to-sell-279-million-stake?srnd=homepage-americas&amp;sref=TBDibEcD">According to Bloomberg</a>, a single shareholder is offering to sell around 16 million shares, which is expected to price at 16.01 euros ($17.46) per share. The transaction could generate roughly 256 million euros ($279 million) in gross proceeds for the seller. The deal is being arranged by<a href="https://www.benzinga.com/news/earnings/24/10/41318123/goldman-sachs-gears-up-for-q3-reveal-will-its-earnings-shine-like-other-major-banks"> Goldman Sachs</a>, though Deutsche Bank has declined to comment.
This development comes amid a broader trend of sell-offs in European companies, as stockholders aim to capitalize on high stock prices. Since early September, nearly $11 billion worth of deals have been priced, with banking institutions like Commerzbank, National Bank of Greece and Santander Bank Polska also seeing significant shareholder exits.
Why It Matters: The shareholder's decision to sell may suggest an opportunity to lock in profits as the bank's stock price climbs. This sale occurs just ahead of the bank's third-quarter earnings release, scheduled for Oct. 23, before the market opens. Analysts expect the bank to report estimated earnings per share of 58 cents and revenue of $7.820 billion.
DB Price Action: Deutsche Bank shares were down by 1.80% at $17.44 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14155445/DB-1024x535.png" alt="" class="wp-image-594716" style="width:462px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14155445/DB-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14155445/DB-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14155445/DB-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/14155445/DB.png 1432w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41320155/bitcoin-ethereum-dogecoin-pick-up-steam-btc-entering-fomo-zone-trader-touts">Bitcoin, Ethereum, Dogecoin Pick Up Steam: &#8216;BTC Entering FOMO Zone,&#8217; Trader Touts</a></li>
</ul>
Image Created Via Midjourney.

What's Going On With Deutsche Bank Stock Monday?

The Goldman Sachs Group Selling About 16M Shares Of Deutsche Bank; Price Range €16.01 To Market

WIIM

CARV

CZNB

EWBC

FCNCA

FFWM

FITB

FNWD

FULT

GBCI

HBAN

HOOD

NYCB

SCHW

TIGR

TROW

TRUP

UPST

Shares of banking and financial services stocks are trading higher following better-than-expected financial results from JPMorgan Chase and Wells Fargo.

Banks across the globe have been continuously undertaking restructuring efforts to focus more on core operations. While these efforts are expected to result in elevated expenses, they will aid growth in the long run. While the uneven economic recovery in developed and emerging nations has been hurting revenue growth for companies within the Zacks <a href="https://www.zacks.com/stocks/industry-rank/stocks-in-industry/banks-foreign-12/stocks-in-industry">Foreign Banks</a> Industry, the current high interest rate environment will continue to provide support.
Thus, despite the geopolitical concerns, industry players like HSBC Holdings plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hsbc#NYSE">HSBC</a>), Barclays PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bcs#NYSE">BCS</a>) and Deutsche Bank Aktiengesellschaft (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) are well-poised to gain from relatively high rates.
<h3>About The Industry</h3>
The Zacks Foreign Banks Industry consists of overseas banks with operations in the United States. Since a foreign banking organization may have federal and state-chartered offices in the country, the Federal Reserve plays a major role in supervising their U.S. operations. In addition to providing a broad range of products and services to customers in the United States, the banks offer financial services to corporate clients having businesses in the country. The financial firms establish relations with U.S. corporations operating in their home countries. Some units of foreign banks offer a broad range of wholesale and retail services, and conduct money-market transactions for their parent organizations. Some firms are involved in developing only specialized services.
<h3>3 Foreign Bank Industry Trends To Watch</h3>
High Interest Rate Environment to Aid Top-Line Growth: The efforts undertaken by the central banks across the globe to cushion economies from the pandemic-induced economic slowdown in 2020 (reducing benchmark interest rates to record lows) were successful in aiding immediate economic growth. However, it eroded banks&#39; profitability to a great extent. The pace of economic recovery, which has been uneven in the developed (home to a number of major foreign banks) and emerging nations, also hampered banking operations globally. Nevertheless, almost all central banks across the globe began raising interest rates from the beginning of 2022 to counter inflation, which supported banks&#39; top-line growth. While higher deposit costs might continue to weigh on banks&#39; net interest income and margin growth to some extent, banks are expected to keep getting support amid the current high interest rate environment. Despite the fact that central banks across the globe have started with rate cuts, interest rates are likely to remain relatively high in the near term. The efforts undertaken by most banks to diversify revenue sources to become less dependent on spread income will likely support non-interest income growth. 
Restructuring Efforts Likely to Keep Costs Elevated: Several foreign banks are undertaking business-restructuring efforts. Many banks have either been divesting or closing non-core operations to increase focus on core businesses and regions. While restructuring efforts are expected to boost growth in the long run, these have been leading to higher expenses. Increased costs related to technology upgrades are likely to keep hampering banks&#39; bottom-line growth to some extent in the near term. 
Uneven Global Economic Recovery Poses Concern: After the coronavirus outbreak, business confidence was shattered across the globe as the pandemic loomed over corporate earnings and economic growth. While the economy has recovered from the negative impacts of the pandemic, growth has slowed in some regions because of certain other geopolitical concerns. Banks&#39; performances are directly linked to the performance of the overall economy. Thus, uneven economic growth may hurt banks&#39; finances to an extent in the upcoming period.
<h3>Zacks Industry Rank Indicates Bright Prospects</h3>
The Zacks Foreign Banks Industry is a 66-stock group within the broader Zacks <a href="https://www.zacks.com/stocks/industry-rank/sector/Finance-13">Finance</a> Sector. The industry currently carries a Zacks <a href="https://www.zacks.com/stocks/industry-rank/industries/">Industry Rank</a> #49, which places it in the top 20% of more than 250 Zacks industries. 
The group&#39;s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates outperformance in the near term. Our research shows that the top 50% of the Zacks-ranked industries outperforms the bottom 50% by a factor of more than 2 to 1. 
The industry&#39;s positioning in the top 50% of the Zacks-ranked industries is a result of an impressive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gaining confidence in this group&#39;s growth potential. The industry&#39;s most recent earnings estimates for 2024 have been revised 2.9% higher since the end of June 2024. 
Thus, we present a few stocks from the industry that you may want to keep an eye on. But before that, let us check out the industry&#39;s recent stock market performance and valuation picture.
<h3>Industry Underperforms S&amp;P 500 But Outperforms Finance Sector</h3>
The Zacks Foreign Banks Industry has underperformed the S&amp;P 500 but outperformed its sector in the past two years. 
Stocks in the industry have collectively gained 52.5%. The S&amp;P 500 composite has rallied 56.5% and the Zacks Finance Sector has appreciated 47.2%.
<h3>Two-Year Price Performance</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io1(17).jpg" style="height:341px; width:620px" />
<h3>Industry&#39;s Current Valuation</h3>
One might get a good sense of the industry&#39;s relative valuation by looking at its price-to-tangible book ratio (P/TBV), which is commonly used for valuing banks because of large variations in their earnings results from one quarter to the next. 
The industry currently has a trailing 12-month P/TBV of 2.31X. This compares with the highest level of 2.34X, the lowest level of 0.79X and the median of 1.62X over the past five years. Additionally, the industry is trading at a significant discount compared with the market at large, as the trailing 12-month P/TB for the S&amp;P 500 composite is 14.90X, which the chart below shows.
<h3>Price-to-Tangible Book Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io2(16).jpg" style="height:344px; width:620px" />
As finance stocks typically have a lower P/TBV ratio, comparing foreign banks with the S&amp;P 500 might not make sense to many investors. However, a comparison of the group&#39;s P/TBV ratio with that of its broader sector ensures that it is trading at a decent discount. The Zacks Finance Sector&#39;s trailing 12-month P/TBV of 5.69X and the median level of 4.44X for the same period are above the Zacks Foreign Banks Industry&#39;s ratios.
<h3>Price-to-Tangible Book Ratio</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io3(16).jpg" style="height:339px; width:620px" />
<h3>3 Foreign Banks Worth A&nbsp;Look</h3>
HSBC: Headquartered in London, it is a major global banking and financial services firm with $2.98 trillion in assets as of June 30, 2024. 
The company has been committed to bolstering its performance with a special focus on building operations across Asia. It intends to position itself as a top bank for high-net-worth and ultra-high-net-worth clients in the region. 
In sync with this, the company acquired Citigroup&#39;s retail wealth management business in China in June 2024, whereas it acquired Singapore-based SilkRoad Property Partners Group in January. HSBC re-launched its private banking business in India as the country has been experiencing a surge in the number of super-rich. 
In 2022, HSBC acquired 100% of the issued share capital of AXA Insurance in Singapore and L&amp;T Investment Management Limited. These initiatives will likely help the company strengthen its position in the region, which constitutes more than half of its operations. 
HSBC has been restructuring its operations to further improve operating efficiency. In 2020, it announced the transformation plan to reshape underperforming businesses, simplify complex organizations and reduce costs. The company realized gross savings of $5.6 billion, with cost to achieve a spend of $6.5 billion by 2022-end. HSBC expects to achieve additional cost savings this year, driven by the actions undertaken in 2023. 
In April 2024, the company announced an agreement to divest its Argentina business, whereas in February, HSBC agreed to sell its Armenian unit. The company has already exited retail banking businesses in the United States, Canada, France, New Zealand, Greece and Russia. 
HSBC&#39;s brand, capital strength, extensive global network and positioning enable it to continuously attract and retain clients. The company&#39;s product and service leadership in alternative investments, foreign exchange, credit, investment advice and many other cross-border banking services help it widen its customer base. 
Shares of the company have gained 16.9% on the NYSE in the past year. The Zacks Consensus Estimate for its current-year earnings has moved 2.7% higher in the past 60 days. Currently, HSBC carries a Zacks Rank #2 (Buy). 
You can see <a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link_invideas&amp;ICID=zpi_1link_invideas">the complete list of today&#39;s Zacks #1 Rank (Strong Buy) stocks here</a>.
<h3>Price And Consensus: HSBC</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io4(15).jpg" style="height:350px; width:620px" />

Barclays: Headquartered in London, this Zacks Ranked #3 (Hold) company is a major global banking and financial services firm with &pound;1,576.6 billion ($1,993.5 billion) in total assets as of June 30, 2024. 
Over the past few years, Barclays has been striving to simplify operations and focus on core businesses. As part of its business overhaul, the company announced changes to its operating divisions effective first-quarter 2024. 
In July 2024, the company announced the divestiture of its German consumer finance business, while it announced the disposal of its Italian mortgage portfolio (which was completed in the second quarter of 2024) in April. Additionally, the company has sold $1.1 billion in credit card receivables to Blackstone&#39;s Credit &amp; Insurance segment to bolster lending capacity for Barclays Bank Delaware in the United States. 
This February, the company announced a deal to acquire Tesco&#39;s retail banking business. The move is expected to complement its existing business and strengthen its position in the market. In 2023, Barclays acquired Kensington Mortgage, which bolstered its mortgage business in the U.K. Driven by these initiatives, the company&#39;s profitability is expected to improve over time. 
Moreover, Barclays&#39; initiatives to improve efficiency over the past few years have been bearing fruit, as evident from a fall in expenses. While total operating expenses increased in 2022, 2023 and the first half of 2024, the metric declined, seeing a compound annual growth rate (CAGR) of 2.4% over the six years ended 2021. As BCS&#39; business-restructuring initiatives continue to offer support, overall costs are expected to be manageable. 
Driven by the structural cost actions taken in 2023 and ongoing efficiency investments, expense savings of &pound;1 billion are anticipated in 2024, with a payback of less than two years. By 2026, management expects total gross efficiency savings of &pound;2 billion and the cost-to-income ratio in the high 50s. 
BCS shares have gained 62.1% on the NYSE in the past 12 months. The Zacks Consensus Estimate for the company&#39;s 2024 earnings has moved 1.2% higher in the past 60 days.
<h3>Price And Consensus: BCS</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io5(17).jpg" style="height:350px; width:620px" /> 
Deutsche Bank: Headquartered in Frankfurt am Main, this is the largest bank in Germany and one of the largest financial institutions in the world, as measured by total assets. It offers a wide variety of investment, financial and related products and services. 
Growth in net revenues has been a key strength at Deutsche Bank. The metric has seen a CAGR of 2.7% over the five years ended 2023, with the uptrend persisting in the first six months of 2024. Notably, the bank&#39;s efforts to shift focus from investment banking to more stable businesses, such as private bank, corporate bank and the asset management unit, will likely continue to aid revenues in the upcoming period. 
The bank closed the acquisition of Numis, which is likely to aid the Asset Management segment. Management expects revenues to witness a CAGR of 5.5-6.5% for the period between 2021 and 2025. 
Moreover, solid deposit balances support DB&#39;s financials. The metric witnessed a CAGR of 2% over the five years ended 2023, with the uptrend continuing in the first half of 2024. The company benefits from its well-diversified deposit base across various client segments and regions. Also, its loan-to-deposit ratio reflects a strong and stable funding base. Thus, we believe that the stable deposit balance will strengthen the company&#39;s balance sheet. 
Deutsche Bank has been returning excess capital to shareholders through dividends and share buybacks. At its annual general meeting in May 2024, the bank proposed 2023 dividends of 45 cents per share, aggregating approximately &euro;900 million. This indicates an increase from 30 cents per share paid out in 2022. For 2024 and 2025, the company plans to pay out dividends of 68 cents and &euro;1 per share, respectively. 
The company also has a share repurchase program. In July 2024, the bank completed the share repurchase program launched on March 4, 2024. Under this program, 46.4 million shares were repurchased for &euro; 675 million, bringing cumulative shareholder distributions through dividends and share repurchases to &euro; 3.3 billion since 2022. DB is committed to capital distributions of &euro;8 billion over the financial years 2022-2026. 
The Zacks Consensus Estimate for the company&#39;s 2024 earnings has been revised 3.5% higher over the past 60 days. DB shares have gained 63.3% on the NYSE in the past year. The company currently carries a Zacks Rank of 3.
<h3>Price And Consensus: DB</h3>
<img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/io6(15).jpg" style="height:351px; width:620px" />
<a href="https://www.zacks.com/commentary/2343164/3-stocks-to-consider-from-the-prospering-foreign-banks-industry?cid=CS-BENZ-FT-industry_outlook-2343164">To read this article on Zacks.com click here.</a>

Each week,&nbsp;Benzinga's Stock Whisper Index&nbsp;uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the&nbsp;<a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Here&#8217;s a look at the Benzinga Stock Whisper Index for the week of Sept. 20:
Barrick Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>): The gold-mining company saw increased interest from readers this week on the heels of a 50 basis point cut to interest rates by the Federal Reserve, which saw gold prices rise. The interest also comes after Barrick Gold CEO Mark Bristow spoke at the Gold Forum Americas earlier this week and<a href="https://www.benzinga.com/news/24/09/40915786/barrick-forecasts-strong-organic-growth-by-2030-ceo-bristow-touts-undervaluation"> said the company expects </a>30% growth in gold-equivalent ounces by the end of the decade from its existing assets. 
Bristow's comments emphasized the company's current mines and those in development, as the industry experiences a surge in merger and acquisition activity. The CEO also highlighted how the company is expanding its copper portfolio, which could be something exciting to watch for investors.
Barrick shares were down 2% over the last five trading days, as seen on the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1">Benzinga Pro chart</a> below. The stock is up 14% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="483" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121633/Screenshot-183.png" alt="" class="wp-image-558808" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121633/Screenshot-183.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121633/Screenshot-183-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121633/Screenshot-183-768x371.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Galmed Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLMD#NASDAQ">GLMD</a>): The biopharmaceutical company <a href="https://www.benzinga.com/news/24/09/40941193/galmed-pharmaceuticals-stock-is-soaring-thursday-heres-why">saw shares soar </a>during the week after an announcement on drug development activities. Galmed plans to add drug developments that target cardiac fibrosis and colorectal and hepatic cancers. The company will release data from the studies during the fourth quarter.
"The conditions Galmed plans to focus upon in the coming years are major public health problems impacting millions of people worldwide and posing huge financial burden on health providers," Galmed CEO Allen Baharaff said.
Large interest in Galmed saw shares halted several times during the trading week. Helping with volatility in the biopharmaceutical company is the low-float of the stock with around 625,000 shares available according to Benzinga Pro. Low-float stocks can often see high volatility on company announcements.
The stock was up 160% over the last five days and up nearly 100% year-to-date in 2024.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="993" height="502" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121656/Screenshot-184.png" alt="" class="wp-image-558810" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121656/Screenshot-184.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121656/Screenshot-184-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121656/Screenshot-184-768x388.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
Read Also:&nbsp;<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40691773/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-august-2024-where-do-tesla-n" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?</a>
ServiceNow Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>): The software company is seeing a large increase in interest from readers ahead of its third-quarter financial results. Analysts expect the company to report revenue of $2.74 billion, up from $2.29 billion in last year's third quarter.
The company has beaten analyst revenue estimates in six straight quarters. Analysts expect the company to report earnings per share of $3.46, up from $2.92 in last year's third quarter. ServiceNow has beaten earnings estimates from analysts in more than 20 straight quarters.
The company's earnings report will show investors and analysts whether revenue growth and AI platform demand are continuing to strengthen. The company saw subscription revenue up 23% year-over-year in <a href="https://www.benzinga.com/news/earnings/24/07/39944577/servicenow-q2-earnings-revenue-beat-eps-beat-servicenow-intends-to-reinvent-every-workflow-in-every">the second quarter </a>and said it was helping meet demand from CEOs looking for new growth as ServiceNow reinvents "every workflow, in every company, in every industry with GenAI at the core."
ServiceNow shares are up 4% over the last five days and up 34% year-to-date.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="997" height="514" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121712/Screenshot-185.png" alt="" class="wp-image-558811" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121712/Screenshot-185.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121712/Screenshot-185-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121712/Screenshot-185-768x396.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>): It's not every week that a bank stock makes its way on the Stock Whisper Index, but here we are. Deutsche Bank saw strong interest from readers, which could be due to bank stocks getting a lift after the <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/09/40928301/interest-rates-in-free-fall-what-it-means-for-mortgages-credit-cards-and-your-wallet-a">interest rate cut was announced.</a> 
The move could see lenders have their balance sheets strengthened going forward and see increased demand for loan activity. Deutsche Bank reports third-quarter financial results in October and could comment on demand and what the future looks like for the company and the sector.
Shares were up 5% over the last five days and 24% year-to-date.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121726/Screenshot-186.png" alt="" class="wp-image-558812" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121726/Screenshot-186.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121726/Screenshot-186-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121726/Screenshot-186-768x387.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Stryker Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>): The medical equipment company saw strong interest from readers during the week, which comes on the heels of acquisition announcements, new products <a href="https://www.benzinga.com/quote/SYK/analyst-ratings">and analyst notes</a>. 
The company recently unveiled new foot and ankle solutions that can help restore limb length. Stryker closed its acquisition of privately held care.ai, a company helping with AI-assisted virtual care workflows and smart room technology. The company said the acquisition will help accelerate its digital vision and could expand its healthcare IT business. 
On Friday, Stryker closed its acquisition of NICO Corporation, a company with a surgery method for tumor and intracerebral hemorrhage procedures. Stryker also announced an acquisition of pain management company Vertos Medical in August. Together, the acquisitions and new products could have investors excited about the company's future and its potential diversification efforts.
Piper Sandler recently maintained an Overweight rating and a $380 price target on the stock. Wolfe Research initiated coverage with an Outperform rating and a $405 price target.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="993" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121742/Screenshot-187.png" alt="" class="wp-image-558813" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121742/Screenshot-187.png 993w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121742/Screenshot-187-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20121742/Screenshot-187-768x387.png 768w" sizes="(max-width: 993px) 100vw, 993px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091324&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/08/40420145/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">August 16</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/08/40531771/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">August 23</a></li>
<li><a href="https://www.benzinga.com/exclusives/24/08/40653930/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">August 30</a></li>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40752686/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet" target="_blank" rel="noreferrer noopener">September 6</a></li>
<li><a href="https://www.benzinga.com/top-stories/24/09/40855829/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">September 13 </a></li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40838414/gold-miners-eye-best-1-day-rally-in-6-months-as-gold-hits-fresh-record-highs-todays-environment-">Gold Miners Eye Best 1-Day Rally In 6 Months As Gold Hits Fresh Record Highs: &#8216;Today&#8217;s Environment Closely Resembles The 1970s&#8217;</a></li>
</ul>
Photo: Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

CACC

CFBK

CRBG

FSFG

VBFC

Shares of bank stocks are trading lower in possible sympathy with Ally, which fell after the company's CFO noted credit challenges among borrowers. The sector earlier reacted to Fed Vice Chair for Supervision Barr previewing Basel and GSIB surcharge re-proposals.

Shares of bank stocks are trading lower after Fed Vice Chair for Supervision Barr unveiled Basel and GSIB surcharge re-proposals.

The latest equity research report from Pablo Zuanic of Zuanic &amp; Associates highlights key trends in Canada's cannabis market, noting a deceleration in recreational sales growth.
Data from StatCan reveals that sales for 2Q24 were down 4% year-over-year (YoY), contributing to a 1.3% decline year-to-date (YTD) compared to 14% growth in 1H23. In contrast, Hifyre data shows a 6% YTD growth through August.
If annualized, this growth would project a total<a href="https://www.benzinga.com/topic/canada-cannabis"> recreational market</a> size of C$5.47 billion for calendar year 2024, translating to US$102 per capita.
Get Benzinga&#8217;s exclusive analysis and top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Market Share Shifts Among Top Players</h3>
<a href="https://www.benzinga.com/topic/pablo-zuanic">Zuanic&#8217;s report </a>highlights notable shifts in market share among the top licensed producers (LPs). Tilray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>), once a dominant player, saw its share drop by 1.5 percentage points to 9.6% in August, continuing its decline over recent quarters. Decibel (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DB#TSXV">DB</a>) also experienced a decline, dropping 0.9 percentage points to 5.2%.
Meanwhile, Village Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) experienced strong growth, increasing its market share to 7.9%, up from 6.1% a year ago, representing a 34% year-over-year growth. Similarly, Cronos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) and Organigram (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) posted gains, with Cronos maintaining a steady 5.3% share (up 24% YoY), and Organigram growing its market share to 7.2%, up from 6.6% a year ago, reflecting 15% (YoY) growth.
Additionally, Auxly (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) and Cannara Biotech (unlisted) gained 0.5 points each, reaching 5.2% and 3.4% market shares, respectively.
Here is a breakdown of the major players:
<ul>
<li>Village Farms: sales grew +34% YoY, holding a 7.9% market share in August (up from 6.1% a year ago).</li>
<li>Cronos: +24% YoY growth in sales, maintaining a 5.3% share, consistent with previous quarters.</li>
<li>Organigram: +15% YoY growth in sales, with a market share of 7.2% in August, up from 6.6% a year ago.</li>
<li>Tilray: -20% YoY decline in sales, with a 9.6% market share in August, down from 10.1% earlier in the quarter.</li>
<li>Decibel: -25% YoY decline in sales, holding a 5.3% market share, down from 7.4% a year ago.</li>
</ul>
<h3 class="wp-block-heading">Format Preferences Continue To Evolve</h3>
The Canadian cannabis market is shifting towards newer product formats, with some segments outperforming others. Flower remains the largest category, accounting for 36% of sales in June-August 2024, down from 41% in 1Q23 and 57% in 1Q21. This decline reflects changing consumer preferences, as <a href="https://www.benzinga.com/markets/cannabis/24/06/39508155/900-pre-rolls-per-hour-upgrade-from-manual-to-automatic-speeds-up-joint-production-enhances-marg">pre-rolls</a> and vapes gain market share.
<a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/09/34625368/nasa-precision-meets-cannabis-roi-pre-rolled-infusion-robots-revolutionizing-indust">Pre-rolls</a> now represent 34% of total sales, up from 27% in 1Q23 and 17% in 1Q21. The segment grew 11% year-over-year (YoY) in the June-August period, driven by consumer demand for convenience. Decibel leads with a 10.4% share, though it fell to 9.7% in August. Tilray holds 8.3%, and Organigram has 6.4%.
<a href="https://www.benzinga.com/general/biotech/24/08/40341814/tony-starks-choice-vape-synergy-innovations-strategic-move-to-restore-brands-identity-lead-market">Vapes </a>account for 16% of sales, up from 15% in 1Q22 and 14% in 1Q21, supported by 8% yoy growth. Motif Labs leads with 20.6%, followed by Auxly (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) at 12.4%, up from 10.7% in 2Q24.
Other formats, like concentrates, edibles, beverages, and oils, hold smaller shares. Concentrates and edibles each represent 5%, while <a href="https://www.benzinga.com/topic/cannabis-beverages">beverages </a>and oils account for 2% each. Concentrates grew 5% YoY, while edibles declined by 5%. Beverages saw a 6% YoY increase, indicating gradual consumer adoption.
Read Next: S<a href="https://www.benzinga.com/markets/cannabis/24/08/40631613/sndl-wins-bid-for-indiva-secures-major-deal-to-boost-cannabis-edibles-market-share-in-canada">NDL Wins Bid For Indiva, Secures Major Deal To Boost Cannabis Edibles Market Share In Canada</a>

Cannabis Flower? No, Thanks: Canadians Shift To Pre-Rolls & Vapes As Market Eyes C$5.47B

Barclays analyst Flora Bocahut upgrades Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) from Equal-Weight to Overweight.

Upgrades

Barclays Upgrades Deutsche Bank to Overweight

Deutsche Bank AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) shares are trading higher today. The company <a href="https://www.db.com/news/detail/20240821-deutsche-bank-reaches-settlements-with-a-large-share-of-the-plaintiffs-in-postbank-takeover-litigation-matter-media-release?language_id=1">stated</a> that it has made substantial progress in its discussions with plaintiffs regarding the litigation over the Postbank takeover and the offer price paid to former Postbank shareholders.
On Thursday, the company reached agreements with over 80 plaintiffs, covering nearly 60% of the total claims.
The settlements are based on an offer of €31 per share, as proposed by the bank, and include a settlement with the largest individual plaintiff, who represents around one-third of all claims.
Elliott Investment Management is receiving nearly €200 million ($222 million) from Deutsche Bank to resolve the long-running legal dispute, Bloomberg <a href="https://news.bloomberglaw.com/mergers-and-acquisitions/elliott-gets-200-million-payday-from-deutsche-bank-settlement" target="_blank" rel="noreferrer noopener">reported</a>, citing people with knowledge of the matter. The report mentioned that the activist hedge fund was the largest plaintiff in the litigation over the Postbank takeover.
Deutsche Bank expects the settlement agreements reached so far to utilize around 45% of the total provisions set aside for the claims covered by these agreements.
The remaining provisions related to these plaintiffs will be released, which will have a positive impact of about €430 million on the bank&#8217;s pre-tax profit in the third quarter.
If Deutsche Bank reaches settlement agreements with additional plaintiffs, it could lead to further positive impacts on the total provisions set aside for the litigation.
In July, the bank reported first-half <a target="_blank" href="https://www.db.com/news/detail/20240724-deutsche-bank-reports-on-the-second-quarter-of-2024?language_id=1" rel="noreferrer noopener">2024</a> net revenue growth of 2% to €15.4 billion, with profit before tax at €2.4 billion-€3.8 billion excluding the Postbank litigation provision compared to €3.3 billion in the first half of 2023.
Price Action: DB shares are up 0.96% at $16.36 at the last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40523059" target="_blank" rel="noreferrer noopener">Mark Zuckerberg&#8217;s Twitter-Clone Threads Explores Ad Integration, But Company Says &#8216;There Is No Immediate Timeline For Monetization&#8217; Yet</a></li>
</ul>

What's Going On With Deutsche Bank Stock Friday?

Deutsche Bank (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) has achieved notable progress in talks with claimants involved in the legal dispute regarding its takeover of Postbank and the compensation paid to former Postbank shareholders.&nbsp;
The bank has reached settlement agreements with more than 80 claimants, who collectively make up nearly 60% of all claims in this lawsuit. These agreements are settled upon the bank&#39;s suggested price of &euro;31 ($34.5) per share. Among the claimants who agreed to a settlement also represented about one-third of all claims.
In April 2024, Deutsche Bank said that it could face claims up to &euro;1.3 billion ($1.4 billion) in a legal battle with former Postbank shareholders about its 2010 takeover. The former Postbank shareholders argued that a higher price should have been offered.
Deutsche Bank anticipates that the settlement agreements reached so far will burn approximately 45% of the total provisions taken for the claims of plaintiffs covered by the agreements. The remaining provisions linked to these specific plaintiffs will be released. It is expected that this action will positively affect the bank&#39;s tax profit for the third quarter by nearly &euro;430 million ($478.6 million). If Deutsche Bank enters into settlement agreements with additional claimants, this could have a positive impact on the overall litigation provisions.
In sync with this news, on Apr 26, 2024, the Higher Regional Court of Cologne looked into claims from former Postbank shareholders. The court hinted that it might back some of these claims in a future decision. Deutsche Bank didn&#39;t agree with the court&#39;s view. Still, it noted that the court&#39;s comments could influence an estimation of future financial outflows. The provision of &euro;1.3 billion for litigation related to the Postbank takeover resulted in a loss in the second quarter of 2024.
Over the past six months, shares of DB have gained 17.1% on the NYSE compared with the industry&#39;s growth of 13.4%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/b4/75073.jpg?v=638750238" />
Image Source: Zacks Investment Research
Currently, Deutsche Bank carries a Zacks Rank #2 (Buy).
Due to the nature of its business, Deutsche Bank is involved in litigation, arbitration and regulatory proceedings in Germany and several jurisdictions outside Germany. The bank carried significant legal settlement costs in the past, which adversely impacted its financials. The recent litigation related to the acquisition of Postbank is likely to keep the expense fairly high. As a result, higher legal expenses are expected to continue putting pressure on DB&#39;s financials in the near term.
<h2>Legal Issues Faced by Other Finance Companies</h2>
In the first half of August, Piper Sandler Companies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pipr#NYSE">PIPR</a>) announced that it has agreed to pay a total civil penalty of $16 million to U.S. regulators for record-keeping failures. To settle investigations into its record-keeping practices, PIPR will pay $14 million to the Securities and Exchange Commission (&quot;SEC&quot;) and $2 million to the Commodity Futures Trading Commission (&quot;CFTC&quot;).
At the same time, Wells Fargo (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wfc#NYSE">WFC</a>) was also fined for its record-keeping lapses. The crackdown, led by the SEC and the CFTC, underlined the significance of keeping accurate records of employee communications in the financial industry. WFC had incurred the highest penalty among the firms targeted, amounting to $200 million.
<a href="https://www.zacks.com/stock/news/2325930/deutsche-bank-db-settles-60-of-claims-related-to-postbank-takeover?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2325930">To read this article on Zacks.com click here.</a>

Invesco EQV European Equity Fund Q3 2024 Commentary

In a report released today, Anke Reingen from RBC Capital maintained a Buy rating on Deutsche Bank AG (DB – Research Report), with a price target o...

RBC Capital Keeps Their Buy Rating on Deutsche Bank AG (DB)

CFRA predicts that banks will outperform the benchmark S&P 500 in 2025

The financial sector is a wise investment due to AI-driven efficiencies, regulatory shifts, global growth, and rising demand for digital banking and financial services, providing lucrative opportunities. Therefore, financial stocks such as Deutsche Bank (DB), Woori Financial Group (WF), and Barclays (BCS) could be strong investments for value investors. Keep reading... The financial sector is flourishing, driven by global rate cuts, increased capital investments, AI-driven efficiencies, and opportunities in fixed-income assets, all benefiting foreign banks. Their diversification, crucial role in financing infrastructure, and adaptability to evolving markets position them as resilient and appealing investment options amid innovation and economic shifts.
Therefore, investors might consider fundamentally strong financial stocks like Deutsche Bank Aktiengesellschaft (<a href="https://stocknews.com/stock/DB/">DB</a>), Woori Financial Group Inc. (<a href="https://stocknews.com/stock/WF/">WF</a>), and Barclays PLC (<a href="https://stocknews.com/stock/BCS/">BCS</a>), which offer attractive valuations.
Banks are embracing AI and automation to boost efficiency and transform traditional models for greater productivity. Additionally, easing regulations are driving global mergers, acquisitions, and IPOs, creating lucrative opportunities for foreign financial institutions. According to Statista, the global finance market's revenue is expected to grow at a <a href="https://www.statista.com/outlook/amo/app/finance/worldwide">CAGR of 9.1%</a>, reaching $2.89 billion by 2029.
Moreover, foreign banks are well-positioned to capitalize on global political and economic shifts, offering valuable diversification for investors. Meanwhile, the financial sector is benefiting from increased internet access, technological advancements, and smart risk management. The growing consumer preference for digital banking, payments, and investing is further driving the sector's expansion.
Considering these conducive trends, let's analyze the fundamental aspects of the three <a href="https://stocknews.com/category/foreign-banks/">Foreign Banks</a> picks, starting with number three.
Stock #3: Deutsche Bank Aktiengesellschaft (<a href="https://stocknews.com/stock/DB/">DB</a>)
Headquartered in Frankfurt am Main, Germany, DB is a stock corporation offering corporate and investment banking, along with asset management products and services, to private individuals, corporate entities, and institutional clients worldwide. It operates through its Corporate Bank, Investment Bank, Private Bank, and Asset Management segments.
In terms of forward <a href="https://www.investopedia.com/terms/p/price-to-salesratio.asp">Price/Sales</a>, DB is trading at 1.05x, which is 68% lower than the 3.27x industry average.
DB's total net revenues for the fiscal third quarter ended September 30, 2024, increased 1.3% year-over-year to €7.50 billion ($7.88 billion). The company's profit attributable to shareholders rose 41.7% from the prior-year quarter to €1.46 billion ($1.53 billion). Additionally, its EPS reached €0.81, marking a 44.6% year-over-year increase.
Street expects DB's revenue for the quarter ending December 31, 2024, to increase 4.2% year-over-year, reaching $7.54 billion. Over the past year, the stock has gained 38.1% to close the last trading session at $17.08.
DB's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its bright prospects. It has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
DB has a B grade for Value and Stability. It is ranked #11 out of 90 stocks in the <a href="https://stocknews.com/category/foreign-banks/">Foreign Banks</a> industry. To access the additional ratings of DB for Growth, Momentum, Sentiment, and Quality, <a href="https://stocknews.com/stock/DB/">click here</a>.
Stock #2: Woori Financial Group Inc. (<a href="https://stocknews.com/stock/WF/">WF</a>)
Headquartered in Seoul, South Korea, WF is a financial holding company that operates as a commercial bank providing a range of financial products and services to individuals, corporations, and small- and medium-sized enterprises in Korea. It operates through Banking, Credit Card, Capital, Investment Banking, and Other segments.
In terms of forward non-GAAP P/E, WF's 4.16x is 69.3% lower than the 13.51x industry average. Likewise, its 1.19x forward Price/Sales is 63.7% lower than the 3.27x industry average. Moreover, its 0.37x forward non-GAAP PEG is 74.9% lower than the 1.48x industry average.
WF's net operating revenue for the nine months ended September 30, 2024, increased by 6.6% year-over-year to KRW7.99 trillion ($5.69 billion). The company's operating income rose to KRW3.58 trillion ($2.55 billion), up 6.4% from the prior-year period. Moreover, WF's net income grew by 9.1% year-over-year, reaching KRW2.72 trillion ($1.93 billion).
Analysts expect WF's EPS and revenue for the quarter ending December 31, 2024, to increase 284.9% and 4.3% year-over-year to $1.13 and $1.84 billion, respectively. It surpassed the consensus EPS estimates in three of the trailing four quarters. Over the past year, WF's stock has gained 19.5% to close the last trading session at $35.86.
WF's POWR Ratings reflect strong prospects. It has an overall rating of B, equating to a Buy in our proprietary rating system.
It has an A grade for Momentum and a B for Value, Stability, and Sentiment. It is ranked #5 in the same industry. Beyond what we stated above, we also have given WF grades for Growth and Quality. Get all of WF's ratings <a href="https://stocknews.com/stock/WF/">here</a>.
Stock #1: Barclays PLC (<a href="https://stocknews.com/stock/BCS/">BCS</a>)
Headquartered in London, United Kingdom, BCS provides various financial services across the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through its Barclays UK and Barclays International divisions.
In terms of forward Price/Sales, BCS' 1.46x is 55.2% lower than the 3.27x industry average.
For the fiscal third quarter that ended on September 30, 2024, BCS' total income stood at £6.55 billion ($8.30 billion), up 4.6% year-over-year. Additionally, its attributable profit and earnings per ordinary share increased 22.8% and 28.9%, respectively, from the prior-year, reaching £1.56 billion ($1.98 billion) and 10.70p.
For the quarter ending December 31, 2024, BCS' revenue is expected to increase 7.4% year-over-year to $7.59 billion. Its EPS for fiscal 2024 is expected to rise 8.6% year-over-year to $1.47. The stock has gained 85% over the past year to close the last trading session at $13.36.
BCS' POWR Ratings reflect a favorable outlook. It has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
It has a B grade for Growth, Value, and Sentiment. It is ranked first in the Foreign Banks industry. To see BCS' Momentum, Stability, and Quality ratings, <a href="https://stocknews.com/stock/BCS/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
BCS shares were trading at $13.52 per share on Tuesday morning, up $0.16 (+1.20%). Year-to-date, BCS has gained 79.17%, versus a 28.16% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/bcs-db-wf-3-financial-stocks-with-attractive-valuations-to-consider/>3 Financial Stocks With Attractive Valuations to Consider</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Financial Stocks With Attractive Valuations to Consider

In a report released today, Kian Abouhossein from J.P. Morgan maintained a Buy rating on Deutsche Bank AG (DB – Research Report), with a price targ...

Deutsche Bank AG (DB) Receives a Buy from J.P. Morgan

There's a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Progressive (PGR – Research Report) and Deutsche Bank...

Analysts' Top Financial Picks: Progressive (PGR), Deutsche Bank AG (DB)

In a report released today, Paola Sabbione from Barclays maintained a Buy rating on Deutsche Bank AG (DB – Research Report), with a price target of...

Barclays Remains a Buy on Deutsche Bank AG (DB)

Deutsche Bank's (DB) New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have decreased their prime len...


Daniel GoldmanHouse (D-NY)	$1K - $15K	stock	Sale	Aug 13, 2023	Jul 10, 2023	House
Daniel GoldmanHouse (D-NY)	$15K - $50K	stock	Sale	Apr 17, 2023	Mar 31, 2023	House

Government Trades

Deutsche Bank AG

top performing DB trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga